ERG monitoring of retinal function during systemic chemotherapy for retinoblastoma
- 18 March 2012
- journal article
- case report
- Published by BMJ in British Journal of Ophthalmology
- Vol. 96 (6) , 877-880
Abstract
Background/aims We have previously introduced electroretinography (ERG) as a proxy for visual function to monitor for retinal toxicity due to intra-arterial chemotherapy for retinoblastoma in young children. In this paper, we report ERG results for patients with retinoblastoma receiving initial treatment with systemic chemotherapy. Methods Inclusion criteria were patients presenting with retinoblastoma at Results Four patients were treated for bilateral retinoblastoma. All eyes responded well to systemic chemotherapy. 30-Hertz flicker ERGs improved during treatment in all eyes, significantly in six of eight eyes, and at least in one eye of each patient. Conclusion Effective systemic chemotherapy for retinoblastoma in children who are too small for intra-arterial chemotherapy is compatible with significant increases in ERG amplitudes, even in eyes presenting with extinguished ERGs. ERG signals may increase independent of resolution of retinal detachment.Keywords
This publication has 6 references indexed in Scilit:
- Intra-arterial Chemotherapy for the Management of RetinoblastomaArchives of Ophthalmology (1950), 2011
- Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastomaDocumenta Ophthalmologica, 2009
- A phase II trial of carboplatin for intraocular retinoblastomaPediatric Blood & Cancer, 2007
- Long-term Visual Outcome Following Chemoreduction for RetinoblastomaArchives of Ophthalmology (1950), 2005
- Visual outcomes in children with bilateral retinoblastomaJournal of American Association for Pediatric Ophthalmology and Strabismus, 1999
- Time courses for maturation of electroretinogram responses from infancy to adulthoodDocumenta Ophthalmologica, 1998